Results 171 to 180 of about 34,159,249 (310)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

An approximate-copula distribution for statistical modeling. [PDF]

open access: yesPLoS Comput Biol
Ji SS, Chu BB, Zhou H, Lange K.
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Statistical modeling of days alive out-of-hospital: An illustration using the SSU trial. [PDF]

open access: yesJ Clin Transl Sci
Wu X   +16 more
europepmc   +1 more source

Statistical Policy Working Paper 16. A Comparative Study of Reporting Units in Selected Employer Data Systems

open access: yes
The Employer Reporting Unit Match Study (ERUMS) was a pilot record linkage study carried out under the auspices of the Federal Committee on Statistical Methodology (FCSM), Office of Management and Budget.
United States. Federal Committee on Statistical Methodology
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Lasercom Uncertainty Modeling and Optimization Simulation (LUMOS): a Statistical Approach to Risk-tolerant Systems Engineering for Small Satellites

open access: yes, 2019
In contrast to large-budget space missions, risk-tolerant platforms such as nanosatellites may be better positioned to exchange moderate performance uncertainty for reduced cost and improved manufacturability.
Cahoy, Kerri   +3 more
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy